Hybrid Micro-macro Electrodes in Patients With Epilepsy
NCT: NCT05335187 · RECRUITING
Brief Summary
The aim of the MicroEPI study is to know whether it is possible to use safely a medical device (a micro-electrode) that allows recording the activity of neurons in the human brain. Patients who suffer from drug-resistant epilepsy and who are candidates to epilepsy surgery to alleviate their condition sometimes require the implantation of intracranial EEG electrodes for a few weeks, in order to determine as best as possible which region of the brain to operate on. In the MicroEPI study, some of these electrodes will also comprise micro-electrodes, allowing us to record the activity of the patients' neurons during their epileptic seizures.
Frequently Asked Questions
What is Hybrid Micro-macro Electrodes in Patients With Epilepsy?
Hybrid Micro-macro Electrodes in Patients With Epilepsy is a clinical trial registered under NCT05335187. Current status: RECRUITING.
What is the status of NCT05335187?
The current status of NCT05335187 (Hybrid Micro-macro Electrodes in Patients With Epilepsy) is: RECRUITING.
When did Hybrid Micro-macro Electrodes in Patients With Epilepsy start?
Hybrid Micro-macro Electrodes in Patients With Epilepsy started on 2023-03-30.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.